Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Abello, Naloxone
2. Curamed, Naloxon
3. Dihydride, Naloxone Hydrochloride
4. Hydrobromide, Naloxone
5. Hydrochloride Dihydride, Naloxone
6. Hydrochloride, Naloxone
7. Mrz 2593
8. Mrz 2593 Br
9. Mrz 2593-br
10. Mrz 2593br
11. Mrz-2593
12. Mrz2593
13. Nalone
14. Naloxon Curamed
15. Naloxon Ratiopharm
16. Naloxon-ratiopharm
17. Naloxone
18. Naloxone Abello
19. Naloxone Hydrobromide
20. Naloxone Hydrochloride Dihydride
21. Naloxone Hydrochloride, (5 Beta,9 Alpha,13 Alpha,14 Alpha)-isomer
22. Naloxone, (5 Beta,9 Alpha,13 Alpha,14 Alpha)-isomer
23. Narcan
24. Narcanti
1. Naloxone Hcl
2. 357-08-4
3. Narcan
4. Narcanti
5. Naloxone (hydrochloride)
6. Evzio
7. Nih 7890
8. En-15304
9. Anhydrous Naloxone Hydrochloride
10. Chebi:31892
11. F850569pqr
12. Nsc-757109
13. (-)-n-allyl-14-hydroxynordihydromorphinone Hydrochloride
14. 357-08-4 (hcl)
15. 17-allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
16. (5alpha)-17-allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
17. (4r,4as,7ar,12bs)-3-allyl-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7ah)-one Hydrochloride
18. Nalonee
19. Mls000069540
20. Naloxonehydrochloride
21. Smr000058766
22. Unii-f850569pqr
23. Prestwick_879
24. Einecs 206-611-0
25. Mfcd00069322
26. Narcan (tn)
27. Kloxxado
28. Evzio (tn)
29. Nafoxone Hydrochloride
30. Nal-oxon Hydrochloride
31. Naloxone Hydrochloride [usan:usp:jan]
32. En 15304
33. Chembl1718
34. C19h21no4.hcl
35. Schembl41390
36. L-n-allyl-14-hydroxynordihydromorphinone Hydrochloride
37. Naloxone Hydrochloride Anhydrous
38. Dtxsid70957097
39. Hms1568g04
40. Naloxone Hydrochloride [mi]
41. Act02626
42. Naloxone Hydrochloride (jp17/usp)
43. Naloxone Hydrochloride [jan]
44. (5a)-17-allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
45. 17-allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
46. Naloxone Hydrochloride [usan]
47. Normorphinone, N-allyl-7,8-dihydro-14-hydroxy-, Hydrochloride, (-)-
48. S3066
49. Naloxone Hydrochloride [vandf]
50. Akos024418753
51. Morphinan-6-one, 17-allyl-4,5-alpha-epoxy-3,14-dihydroxy-, Hydrochloride
52. Naloxone Hydrochloride [mart.]
53. Ccg-220111
54. Cs-1335
55. Ks-5379
56. Naloxone Hydrochloride [who-dd]
57. Nc00587
58. Nsc 757109
59. Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, Hydrochloride, (5.alpha.)-
60. Hy-17417
61. Naloxone Hydrochloride [green Book]
62. Naloxone Hydrochloride [orange Book]
63. Sw197001-3
64. Naloxone Hydrochloride [usp Monograph]
65. D01340
66. Suboxone Component Naloxone Hydrochloride
67. Targiniq Component Naloxone Hydrochloride
68. Naloxone Hydrochloride Anhydrous [who-ip]
69. Talwin Nx Component Naloxone Hydrochloride
70. 357n084
71. Naloxone Hydrochloride Component Of Suboxone
72. Naloxone Hydrochloride Component Of Targiniq
73. Sr-01000597918
74. Sr-01000737374
75. Naloxone Hydrochloride Component Of Talwin Nx
76. Sr-01000597918-1
77. Sr-01000737374-3
78. W-106655
79. Q27114711
80. Naloxoni Hydrochloridum Anhydrous [who-ip Latin]
81. (5alpha)-17-allyl-3,14-dihydroxy-4,5-epoxymorphinan-6-one Hydrochloride
82. 17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one Hydrochloride
83. (17r)-17-allyl-3,14-dihydroxy-6-oxo-4,5alpha-epoxymorphinan-17-ium Chloride
84. (5?)-4,5-epoxy-3,14-dihydro-17-(2-propenyl)morphinan-6-one Hydrochloride
85. (5a)-4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)-morphinan-6-one Hydrochloride
86. (5alpha)-4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)morphinan-6-one Hydrochloride (1:1)
87. (5alpha,17r)-17-allyl-3,14-dihydroxy-6-oxo-4,5-epoxymorphinan-17-ium Chloride
88. 17-allyl-4,5.alpha.-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
89. Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, Hydrochloride, (5alpha)-
90. (4r,4as,12bs)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
91. (4r,4as,7ar,12bs)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
92. (5alpha)-4,5-epoxy-3,14-dihydro-17-(2-pr Openyl)morphinan-6-one Hydrochloride
| Molecular Weight | 363.8 g/mol |
|---|---|
| Molecular Formula | C19H22ClNO4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 363.1237359 g/mol |
| Monoisotopic Mass | 363.1237359 g/mol |
| Topological Polar Surface Area | 70 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 594 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Evzio |
| PubMed Health | Naloxone (Injection) |
| Drug Classes | Toxicology-Antidote Agent |
| Drug Label | EVZIO (naloxone hydrochloride injection, USP) is a pre-filled, single-use auto-injector. EVZIO is not made with natural rubber latex. Chemically, naloxone hydrochloride is the hydrochloride salt of 17-Allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one h... |
| Active Ingredient | Naloxone hydrochloride |
| Dosage Form | Solution |
| Route | Intramuscular, subcutaneous |
| Strength | 0.4mg/0.4ml |
| Market Status | Prescription |
| Company | Kaleo |
| 2 of 4 | |
|---|---|
| Drug Name | Naloxone hydrochloride |
| Drug Label | Ampul, Fliptop Vial, Opioid AntagonistProtect from light.RxNaloxone Hydrochloride Injection, USP is a sterile, nonpyrogenic solution of naloxone hydrochloride in water for injection. Each milliliter (mL) contains 0.4 mg naloxone hydrochloride and sod... |
| Active Ingredient | Naloxone hydrochloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 1mg/ml; 0.4mg/ml |
| Market Status | Prescription |
| Company | Hospira; Intl Medication; Mylan Institutional |
| 3 of 4 | |
|---|---|
| Drug Name | Evzio |
| PubMed Health | Naloxone (Injection) |
| Drug Classes | Toxicology-Antidote Agent |
| Drug Label | EVZIO (naloxone hydrochloride injection, USP) is a pre-filled, single-use auto-injector. EVZIO is not made with natural rubber latex. Chemically, naloxone hydrochloride is the hydrochloride salt of 17-Allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one h... |
| Active Ingredient | Naloxone hydrochloride |
| Dosage Form | Solution |
| Route | Intramuscular, subcutaneous |
| Strength | 0.4mg/0.4ml |
| Market Status | Prescription |
| Company | Kaleo |
| 4 of 4 | |
|---|---|
| Drug Name | Naloxone hydrochloride |
| Drug Label | Ampul, Fliptop Vial, Opioid AntagonistProtect from light.RxNaloxone Hydrochloride Injection, USP is a sterile, nonpyrogenic solution of naloxone hydrochloride in water for injection. Each milliliter (mL) contains 0.4 mg naloxone hydrochloride and sod... |
| Active Ingredient | Naloxone hydrochloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 1mg/ml; 0.4mg/ml |
| Market Status | Prescription |
| Company | Hospira; Intl Medication; Mylan Institutional |
Treatment of opioid-induced constipation
Narcotic Antagonists
Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
79
PharmaCompass offers a list of Naloxone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Naloxone Hydrochloride manufacturer or Naloxone Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naloxone Hydrochloride manufacturer or Naloxone Hydrochloride supplier.
A NC00587 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NC00587, including repackagers and relabelers. The FDA regulates NC00587 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NC00587 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NC00587 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A NC00587 supplier is an individual or a company that provides NC00587 active pharmaceutical ingredient (API) or NC00587 finished formulations upon request. The NC00587 suppliers may include NC00587 API manufacturers, exporters, distributors and traders.
click here to find a list of NC00587 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A NC00587 DMF (Drug Master File) is a document detailing the whole manufacturing process of NC00587 active pharmaceutical ingredient (API) in detail. Different forms of NC00587 DMFs exist exist since differing nations have different regulations, such as NC00587 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NC00587 DMF submitted to regulatory agencies in the US is known as a USDMF. NC00587 USDMF includes data on NC00587's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NC00587 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NC00587 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The NC00587 Drug Master File in Japan (NC00587 JDMF) empowers NC00587 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the NC00587 JDMF during the approval evaluation for pharmaceutical products. At the time of NC00587 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of NC00587 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a NC00587 Drug Master File in Korea (NC00587 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of NC00587. The MFDS reviews the NC00587 KDMF as part of the drug registration process and uses the information provided in the NC00587 KDMF to evaluate the safety and efficacy of the drug.
After submitting a NC00587 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their NC00587 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of NC00587 suppliers with KDMF on PharmaCompass.
A NC00587 CEP of the European Pharmacopoeia monograph is often referred to as a NC00587 Certificate of Suitability (COS). The purpose of a NC00587 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of NC00587 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of NC00587 to their clients by showing that a NC00587 CEP has been issued for it. The manufacturer submits a NC00587 CEP (COS) as part of the market authorization procedure, and it takes on the role of a NC00587 CEP holder for the record. Additionally, the data presented in the NC00587 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the NC00587 DMF.
A NC00587 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. NC00587 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of NC00587 suppliers with CEP (COS) on PharmaCompass.
A NC00587 written confirmation (NC00587 WC) is an official document issued by a regulatory agency to a NC00587 manufacturer, verifying that the manufacturing facility of a NC00587 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting NC00587 APIs or NC00587 finished pharmaceutical products to another nation, regulatory agencies frequently require a NC00587 WC (written confirmation) as part of the regulatory process.
click here to find a list of NC00587 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NC00587 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NC00587 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NC00587 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NC00587 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NC00587 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NC00587 suppliers with NDC on PharmaCompass.
NC00587 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NC00587 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right NC00587 GMP manufacturer or NC00587 GMP API supplier for your needs.
A NC00587 CoA (Certificate of Analysis) is a formal document that attests to NC00587's compliance with NC00587 specifications and serves as a tool for batch-level quality control.
NC00587 CoA mostly includes findings from lab analyses of a specific batch. For each NC00587 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NC00587 may be tested according to a variety of international standards, such as European Pharmacopoeia (NC00587 EP), NC00587 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NC00587 USP).